Chronic Hypoparathyroidism

Advertisement

cGxPJobs Banner

Pendopharm and Ascendis Pharma Gain Canada Reimbursement Recommendation for Yorvipath

MONTREAL, Quebec, September 2, 2026 Pendopharm, a division of Pharmascience Inc., in collaboration with Ascendis Pharma A/S, announced that...

By cGxPwire Editor
September 4, 2026

Read More

Advertisement

cGxPJobs

Directory